| |
| |
Preface | |
| |
| |
| |
Introduction | |
| |
| |
Scope of the study | |
| |
| |
Important contributions | |
| |
| |
Plan of the study | |
| |
| |
| |
Some basic tools and concepts | |
| |
| |
Utility maximization | |
| |
| |
A health production function | |
| |
| |
Intertemporal models | |
| |
| |
Introducing risk | |
| |
| |
Some further comments on risk | |
| |
| |
More complex intertemporal models | |
| |
| |
Appendix | |
| |
| |
| |
Evaluating health changes in a certain world | |
| |
| |
Two money measures of a change in health | |
| |
| |
On the properties of compensated money measures | |
| |
| |
An example: using CV and EV | |
| |
| |
Overall versus instantaneous money measures | |
| |
| |
A health production function approach | |
| |
| |
Using market data to evaluate changes in health | |
| |
| |
Appendix | |
| |
| |
| |
Money measures in a risky world | |
| |
| |
Introducing money measures in a risky world | |
| |
| |
A WTP locus | |
| |
| |
Evaluating changes in mortality, and the value of a statistical life | |
| |
| |
Endogenous risks and altruism | |
| |
| |
Changes in wealth and the value of health | |
| |
| |
Intertemporal models | |
| |
| |
Appendix | |
| |
| |
| |
Evaluating health risks: practical methodologies | |
| |
| |
The contingent valuation method | |
| |
| |
Closed-ended techniques | |
| |
| |
A useful interpretation of WTP measures | |
| |
| |
CVM studies of health risks | |
| |
| |
The human capital approach | |
| |
| |
Market-based estimation methods | |
| |
| |
The value of a statistical life | |
| |
| |
Appendix | |
| |
| |
| |
Contingent valuation studies of health care | |
| |
| |
Empirical studies of the WTP for health care: a brief review | |
| |
| |
A study of high blood pressure | |
| |
| |
The results | |
| |
| |
Useful formulae for the computation of the mean WTP | |
| |
| |
Appendix | |
| |
| |
| |
Aggregation | |
| |
| |
The social welfare function | |
| |
| |
Project evaluations | |
| |
| |
Pragmatic views on the aggregation problem | |
| |
| |
An illustration: how to assess a treatment | |
| |
| |
Altruism | |
| |
| |
Altruism in cost-benefit analysis | |
| |
| |
Appendix | |
| |
| |
| |
Further evaluation issues in a risky world | |
| |
| |
The value of information | |
| |
| |
A health production function model | |
| |
| |
Using the model to assess health changes | |
| |
| |
On the value of changes in life expectancy | |
| |
| |
Appendix | |
| |
| |
| |
Concluding remarks on related approaches | |
| |
| |
Qalys and hyes | |
| |
| |
Risk-risk and risk-dollar trade-offs | |
| |
| |
Cost-effectiveness analysis | |
| |
| |
Appendix | |
| |
| |
Notes | |
| |
| |
Bibliography | |
| |
| |
Index | |